JUAN JOSÉ GÓMEZ DOBLAS – ENSAYO CLÍNICO CON MEDICAMENTOS – JANSSEN RESEARCH & DEVELOPMENT LLC
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation
by prodriguez | Jul 3, 2024 | Clinical Trials, Ensayos Clínicos - A-03 | 0 comments